Allogene Therapeutics ALLO Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's common stock, shares issued (in shares)?
- Allogene Therapeutics (ALLO) reported common stock, shares issued (in shares) of $244.82M in Q1 2026.
- How has Allogene Therapeutics's common stock, shares issued (in shares) changed year-over-year?
- Allogene Therapeutics's common stock, shares issued (in shares) increased by 12.0% year-over-year, from $218.6M to $244.82M.
- What is the long-term trend for Allogene Therapeutics's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Allogene Therapeutics's common stock, shares issued (in shares) has grown at a 10.3% compound annual growth rate (CAGR), from $140.47M to $229.41M.